Results 241 to 250 of about 802,486 (287)
Hepatitis B virus confers innate immunity evasion through hepatitis B virus-miR-3 down-regulation of cGAS-Sting-IFN signaling. [PDF]
Xu ZY+5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Hepatitis B virus immunopathogenesis.
Annual Review of Immunology, 1995Approximately 5% of the world population is infected by the hepatitis B virus (HBV) that causes a necroinflammatory liver disease of variable duration and severity. Chronically infected patients with active liver disease carry a high risk of developing cirrhosis and hepatocellular carcinoma.
F. Chisari, C. Ferrari
semanticscholar +5 more sources
JAAPA, 2016
The goal of chemoprevention for chronic hepatitis B (CHB) must be to improve the quality and the outcomes of care for patients with CHB. This chapter focuses on the human hepatitis B virus (HBV). HBV is an enveloped, 3.2-kb double-stranded DNA virus which may be classified into eight major genotypes (A to H) based on a nucleotide diversity of 8% or ...
Stephen Locarnini+2 more
+7 more sources
The goal of chemoprevention for chronic hepatitis B (CHB) must be to improve the quality and the outcomes of care for patients with CHB. This chapter focuses on the human hepatitis B virus (HBV). HBV is an enveloped, 3.2-kb double-stranded DNA virus which may be classified into eight major genotypes (A to H) based on a nucleotide diversity of 8% or ...
Stephen Locarnini+2 more
+7 more sources
Expert Review of Anti-infective Therapy, 2003
(2003). Hepatitis B Virus. Expert Review of Anti-infective Therapy: Vol. 1, No. 3, pp. 357-358.
Gerken, Guido, Jochum, Christoph
openaire +4 more sources
(2003). Hepatitis B Virus. Expert Review of Anti-infective Therapy: Vol. 1, No. 3, pp. 357-358.
Gerken, Guido, Jochum, Christoph
openaire +4 more sources
Trends in Microbiology, 2018
This infographic about hepatitis B virus explores its replication cycle, natural history of infection and pathogenesis, and how this can be controlled and treated. Hepatitis B virus (HBV) is a common worldwide blood-borne pathogen. Chronic hepatitis B can progress to an inactive carrier state, and then, in some patients, give rise to cirrhosis and ...
Ching-Chun Yang+9 more
openaire +4 more sources
This infographic about hepatitis B virus explores its replication cycle, natural history of infection and pathogenesis, and how this can be controlled and treated. Hepatitis B virus (HBV) is a common worldwide blood-borne pathogen. Chronic hepatitis B can progress to an inactive carrier state, and then, in some patients, give rise to cirrhosis and ...
Ching-Chun Yang+9 more
openaire +4 more sources
Nature, 1985
DNA recombinant technology has radically changed hepatitis B virus (HBV) virology. The genetic organization, transcription and replication of the virus are basically understood, structures of integrated HBV sequences in hepatocellular carcinoma have been characterized, and new vaccines produced by recombinant DNA technique are being developed.
Tiollais, Pierre+2 more
openaire +4 more sources
DNA recombinant technology has radically changed hepatitis B virus (HBV) virology. The genetic organization, transcription and replication of the virus are basically understood, structures of integrated HBV sequences in hepatocellular carcinoma have been characterized, and new vaccines produced by recombinant DNA technique are being developed.
Tiollais, Pierre+2 more
openaire +4 more sources
Baillière's Clinical Gastroenterology, 1990
Of all the hepatotropic viruses, HBV is associated with the greatest worldwide morbidity and mortality. This is because of the ease of transmission and the potential for progression to a chronic infective carrier state, with the complications of cirrhosis and hepatocellular carcinoma.
Howard C. Thomas+2 more
openaire +3 more sources
Of all the hepatotropic viruses, HBV is associated with the greatest worldwide morbidity and mortality. This is because of the ease of transmission and the potential for progression to a chronic infective carrier state, with the complications of cirrhosis and hepatocellular carcinoma.
Howard C. Thomas+2 more
openaire +3 more sources
New England Journal of Medicine, 1997
The hepatitis B virus (HBV), discovered in 1966, infects more than 350 million people worldwide.1 Hepatitis B is a leading cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma, accounting for 1 million deaths annually. Knowledge of the intricacies of viral infection and of the molecular biology of this fascinating virus has led to the ...
MARIGNANI M+2 more
openaire +3 more sources
The hepatitis B virus (HBV), discovered in 1966, infects more than 350 million people worldwide.1 Hepatitis B is a leading cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma, accounting for 1 million deaths annually. Knowledge of the intricacies of viral infection and of the molecular biology of this fascinating virus has led to the ...
MARIGNANI M+2 more
openaire +3 more sources
Hepatitis b virus replication in acute hepatitis B, acute hepatitis B virus-hepatitis delta virus coinfection and acute hepatitis delta superinfection [PDF]
To evaluate the effect of hepatitis delta virus on the level of replication of hepatitis B virus and to assess the clinical significance that such an effect might have on the final outcome of the infection, the serological profile of hepatitis B virus DNA was investigated in 153 patients with acute or chronic hepatitis B virus
Jaume Guardia+7 more
openaire +2 more sources